期刊文献+

选择性雌激素受体调节剂对放疗所致卵巢早衰引起骨质丢失的实验研究 被引量:1

Effect of selective estrogen receptor modulators on bone metabolism induced by premature ovarian failure after radiotherapy
原文传递
导出
摘要 目的:通过观察选择性雌激素受体调节剂(雷洛昔芬)对放疗去势大鼠的骨代谢生化指标的影响,探讨选择性雌激素受体调节剂对放疗所致卵巢早衰引起骨质丢失的保护作用。方法:选用3月龄雌性wistar大鼠40只,随机分为4组:假放疗组、放疗组、放疗+雷洛昔芬组、放疗+己烯雌酚组,每组10只,16周后,处死大鼠,腹主动脉取血,检测血清雌二醇、卵泡刺激素,骨钙素及碱性磷酸酶。结果:放疗组及放疗+雷洛昔芬组雌二醇水平明显低于假放疗组,差异有显著意义(P<0.05),而卵泡刺激素水平明显高于假放疗组(P<0.05);放疗组骨钙素和碱性磷酸酶明显高于其他组,差异有显著意义,而另3组间差异不显著。结论:大鼠卵巢放疗可致去势;放疗去势后大鼠有骨质丢失,雷洛昔芬对放疗去势后大鼠的骨丢失和己烯雌酚一样有保护作用。 Objective: To explore the protective effect of selective estrogen receptor modulators (SERMs) on bone metabolism induced by premature ovarian failure (POF) after radiotherapy in rats. Methods: 40 female Wistar rats aged 3 months were randomly divided into 4 groups ( 10 rats in every group) : Group A ( sham radiotherapy), Group B ( radiotherapy), Group C ( radiotherapy and raloxifene) , Group D (radiotherapy and diethylstilbestrol) . All rats were killed 16 weeks later, then levels of estradiol (E2 ), follicle stimulating hormone (FSH), bone gla protein (BGP) and alkaline phosphatase (ALP) in serum were detected. Results: The levels of E2 in group B and group C were lower than that in group A ( P 〈 0. 05 ), while the levels of FSH in group B and group C were higher than that in group A ( P 〈 0. 05 ) ; the levels of BGP and ALP in group B were higher than those in the other groups ( P 〈 0. 05 ) , but there was no significant difference between group A, group C and group D. Conclusion: Rats will be gonadectomy after radiotherapy to ovaries, then bone loss is found in those rats. Rloxifene has protective effect on bone loss of rats induced by gonadeetomy after radiotherapy, which is alike to diethylstilbestrol.
出处 《中国妇幼保健》 CAS 北大核心 2009年第10期1401-1403,共3页 Maternal and Child Health Care of China
基金 湖北省科技厅自然科学基金资助(2005ABA153)
关键词 雷洛昔芬 放疗 去势 骨代谢 Raloxifene Radiotherapy Gonadectomy Bone metabolism
  • 相关文献

参考文献7

  • 1李从铸,翟玉霞.宫颈癌年轻化及其治疗模式的临床研究[J].癌变·畸变·突变,2005,17(1):36-38. 被引量:21
  • 2Ito T, Ishizuka T, Suzuki K et al. Cervical cancer cancer in young Japanese women [J]. Arch Gynecol Obstet, 2000, 264 (2) : 68
  • 3Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial [J].JAMA, 1998, 280:321
  • 4Hulley S, Furberg C, Barrett - Connor E. Heart and Estrogen/progestin Replacement Study FolloW - up ( HERS Ⅱ) : Noncardiovascular disease outcomes during 6.8 years or hormone therapy [ J ] . JAMA, 2002, 288:58
  • 5Hulley S, Grady D, Bush T et al. Randomized trial Of estrogen plus progestin forsecondary prevention of coronary heart disease in postmenopausal women [J] .JAMA, 1998, 280:605
  • 6Craig Jordan V. SERMs: Meeting the Promise of Muhifunctional Medicines [J] . J Natl Cancer Inst, 2007, 99 (5) : 350
  • 7谈志龙,任海龙,白人骁,王学谦.骨质疏松症与骨代谢生化测定指标[J].中国骨质疏松杂志,2006,12(1):89-93. 被引量:44

二级参考文献28

  • 1周丽珍,向青,刘忠厚.合理使用骨质疏松症诊疗的骨代谢标志物指南(2004年版)[J].中国骨质疏松杂志,2004,10(4):397-404. 被引量:22
  • 2薛延.骨质疏松症的生化诊断[J].中国骨质疏松杂志,1995,1(1):58-62. 被引量:66
  • 3Acharki A, Sahraoui S, Benider A, et all. Cancer of the uterine cervix in young women. A retrospective study of 337 cases[J].Bull Cancer, 1997,84: 373.
  • 4Clark MA, Naahas W, Mardert RT, et al . Cervical cancer :Women aged 35 and younger compared to women aged 36 and older[J]. Am J Clin Oncol( CCT) ,1991, 14: 352.
  • 5Brewster WR, DiSaia PJ, Monk B J, et al .Young age as a prognostic factor in cervical cancer:results of a population based study[J]. Am J Obstet Gynecol, 1999, 180: 1 464.
  • 6Odunsi KO, Lele S, Ghamande S, et al.The impact of pre-therapy extraperitoneal surgical staging on the evaluation and treatment of patients with locally advanced cervical cancer[J].Eur J Gynaecol Oncol,2001,22: 325.
  • 7Tabata T,Takeshima N,Nishida H, et al. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin(BOMP)chemotherapy followed by radiotherapy versus radiotherapy alonein stage ⅢB and ⅣA squamous cell carcinoma of the cervix[J]. Anticancer Res,2003,23:2 885.
  • 8王迪浔,主编.钙、磷代谢及紊乱.病理生理学.北京:人民卫生出版社,1996.240-250.
  • 9Drinka PJ.The importance of parathyroid hormone and vitamin D status in the treatment of osteoporosis and renal insufficiency.J Am Med Dir Assoc,2004,5:382-386.
  • 10Gur A,Colpan L,Cevik R,et al.Comparison of zinc excretion and biochemical markers of bone remodelling in the assessment of the effects of alendronate and calcitonin on bone in postmenopausal osteoporosis.Clin Biochem,2005,38:66-72.

共引文献62

同被引文献5

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部